Aptamer Sciences Inc (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 780.00
+25.00 (3.31%)
At close: Jun 30, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 47.61 billion as of June 30, 2026. Its market cap has increased by 35.39% in one year.
Market Cap
47.61B
Enterprise Value
38.14B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
780.00
Market Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 47.61B, a decrease of -79.73%. That is a compound annual growth rate of -24.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 47.61B | 56.02% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 56.24B |
| EyeGene | 55.33B |
| TegoScience | 52.12B |
| Progen | 50.12B |
| Psomagen | 46.36B |
| Parataxis Korea | 44.13B |
| J2KBIO | 42.10B |
| HLB Pep | 40.69B |